Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Led by international and local experts, the Breast Cancer Immunotherapy Conference (BRECIS) will focus on immunobiology and immunotherapeutic ...
Advaxis is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary Lm-LLO platform technology.
The booming field of cancer immunotherapy is predicated on the notion that the human body is built to fight off disease—all we need to do is figure out ...
In a new analysis published in the journal Cancer Biotherapy and ... and antibody immunotherapy trials in patients with metastatic cancer is based on ...
In addition, Dr. Cohen-Dayag will participate in a panel discussion titled Focus on Immunotherapy: The Future at the Cancer Advance Boston ...
Give the immune system too much gas and it can kill its host; don't ease up ... says David H. Munn, a cancer immunology expert at Georgia Regents.
The immune system then attacks the virus as well as the cancer cells. Andtbacka said the biggest plus of this treatment is the lack of side effects.
The second article, "Neoantigens in cancer immunotherapy," was written by Professor Dr. Ton N. M. Schumacher, ... with a primary focus on eACT™ designed to restore the immune system's ability to recognize and eradicate tumors.
TEHRAN (Tasnim) – Scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with ...
Six Cancer Screenings That Could Save Your Life
Here are six cancer screening methods that are crucial to early detection of cancer, including who should get them and more.
Here are six cancer screening methods that are crucial to early detection of cancer, including who should get them and more.
... Institute of LLR hospital said that the heavy metals are mainly responsible for cancers like blood cancer, gall bladder cancer and even liver cancer.
Science Daily Cancer News
Many women diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer, a new study confirms. Overall, 35 percent of women with breast cancer expressed a strong desire for genetic testing, but 43 percent of those women did not have a relevant discussion with a health care professional. The study also found that racial minority patients with a strong desire for testing were less likely than white patients to discuss it with a professional, even though studies show that minority patients are not at lower risk for these mutations.
In a unique partnership demonstrating excellence in "team science," investigators identified a role for the molecule CXCR3 (widely known to regulate the migration of immune cells) as a key mediator of melanoma metastasis. The significance of this work is its descriptions of alternative mechanisms by which tumors move and settle in new locations.
The progressive wasting of muscle and fat tissue throughout the body is one of the most visible and heartbreaking manifestations of cancer, yet little is known about how tumors cause distant tissues to degenerate. Two studies reveal that a tumor-secreted molecule drives the loss of fat and muscle tissue in fly cancer models that replicate key features of tumor-induced wasting in humans. The findings could lead to much-needed therapies for wasting.
Messenger RNAs -- the working copies of genes that are used to assemble proteins -- have typically been ignored as drug targets because they all look about the same. But researchers have found that a subset of mRNAs -- many of which have been linked to cancer -- have unique tags. These short RNA tags bind to a protein, eIF3, that regulates translation at the ribosome, making the binding site a promising target for anticancer drugs.
Researchers have developed a new method to activate genes by synthetically creating a key component of the epigenome that controls how our genes are expressed. The new technology allows researchers to turn on specific gene promoters and enhancers -- pieces of our genomes that control our gene activity -- by chemically manipulating proteins that package our DNA.
The first systematic study has been carried out analyzing the safety of so-called upconversion nanoparticles that may be used to treat skin cancer and other skin diseases. This study is one of the most important steps on the path to new, safe and effective methods to diagnose and treat cancer.
In a breakthrough in the understanding of how cancer does its deadly work, researchers have shown that many cancers -- including nearly all pancreatic cancers -- enslave and deform mitochondria, the powerhouses of cells, to create an environment more conducive to tumor growth.
Erythropoietin combined with radiation therapy does not improve local-regional control in anemic patients with head and neck cancer
Long-term analysis of Radiation Therapy Oncology Group 9903 demonstrates that the addition of erythropoietin did not improve local-regional control for anemic patients with head and neck squamous cell carcinoma who receive radiation therapy or chemoradiation, according to a study.
Pensioners are seven times more likely to get malignant melanoma than 40 years ago, a study confirms. While age is one of the biggest risk factors for melanoma the huge increase in pensioners being diagnosed with the disease is likely to be linked to the cheap package holiday boom dating from the 1960s, and the desirability of having a tanned appearance even at the expense of painful sunburn.
Tambahkan Komentar